Literature DB >> 2479953

Inhibitory effects of beta-adrenergic stimulants on increased vascular permeability caused by passive cutaneous anaphylaxis, allergic mediators, and mediator releasers in rats.

N Inagaki1, T Miura, M Daikoku, H Nagai, A Koda.   

Abstract

The effects of isoproterenol, salbutamol, theophylline, and forskolin on IgE antibody-mediated homologous passive cutaneous anaphylaxis (PCA) and on skin reactions caused by allergic mediators and mediator releasers were investigated in rats. Isoproterenol and salbutamol dose-dependently inhibited the PCA and skin reactions caused by histamine, serotonin, and leukotriene C4 (LTC4), elicited at the same time in the same rat. These agents also dose-dependently inhibited the skin reactions caused by platelet-activating factor (PAF), leukotriene D4 (LTD4), compound 48/80 (48/80), and calcium ionophore A23187 (A23187). Propranolol overcame the inhibitory effect of isoproterenol on PCA and skin reactions in a dose-dependent manner. Theophylline and forskolin showed similar effects as the beta-adrenergic stimulants. These results indicate that beta-adrenergic stimulants inhibit the increased vascular permeability caused by allergic mediators, and suggest that this activity of beta-adrenergic stimulants might play an important role in their antiallergic actions. Inhibition of increased vascular permeability might be mediated via beta-receptors and may be related to the increase in intracellular cyclic AMP levels.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479953     DOI: 10.1159/000138567

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  3 in total

1.  Inhibition by fenoterol of human eosinophil functions including beta2-adrenoceptor-independent actions.

Authors:  A Tachibana; M Kato; H Kimura; T Fujiu; M Suzuki; A Morikawa
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

Review 2.  Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap.

Authors:  Xiaoli Zhang; Yuqing Chen; Liyu Fan; Jiaqi Ye; Junsheng Fan; Xinjie Xu; Danming You; Sihan Liu; Xin Chen; Peng Luo
Journal:  Drug Des Devel Ther       Date:  2018-08-01       Impact factor: 4.162

3.  Optimizing drug inhibition of IgE-mediated anaphylaxis in mice.

Authors:  Suzanne C Morris; Charles Perkins; Crystal Potter; David Parsons; Richard Schuman; Marat V Khodoun; Unni Samavedam; Richard Strait; Fred D Finkelman
Journal:  J Allergy Clin Immunol       Date:  2021-06-26       Impact factor: 14.290

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.